Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring

Acta Oncol. 1997;36(4):413-20. doi: 10.3109/02841869709001289.

Abstract

Prognostic factors and treatment outcome of 71 patients with non-Hodgkin's lymphoma of Waldeyer's ring were analyzed retrospectively. In univariate analyses, unfavorable prognosis was associated with primary disease in the base of the tongue, stage III-IV diseases, B-symptoms, high-grade histology, T-cell phenotype, elevated serum LDH levels, decreased peripheral blood lymphocyte counts, and negative response on delayed type hypersensitivity skin reactions. Multivariate analysis showed that stage III-IV and T-cell phenotype were significant independent risk factors for death. In stage I-II lymphomas, patients with unilateral large or bilateral cervical lymph node involvement had a poorer prognosis. In stage I-II lymphomas with intermediate or high-grade histology, patients who had received radiotherapy with MTCOP-P chemotherapy (pirarubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, peplomycin, and predonisolone) showed significantly better 5-year disease-free survival rate compared with patients treated with radiotherapy alone.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Humans
  • Hypersensitivity, Delayed / immunology
  • L-Lactate Dehydrogenase / blood
  • Lymph Nodes / pathology
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / pathology
  • Lymphoma, Non-Hodgkin / radiotherapy
  • Lymphoma, Non-Hodgkin / therapy*
  • Lymphoma, T-Cell / pathology
  • Lymphopenia / pathology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Phenotype
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Tongue Neoplasms / pathology
  • Tongue Neoplasms / therapy
  • Tonsillar Neoplasms / drug therapy
  • Tonsillar Neoplasms / pathology
  • Tonsillar Neoplasms / radiotherapy
  • Tonsillar Neoplasms / therapy*
  • Treatment Outcome

Substances

  • L-Lactate Dehydrogenase